Modified Vaccinia Virus Ankara (MVA) as Production Platform for Vaccines against Influenza and Other Viral Respiratory Diseases

Modified Vaccinia Virus Ankara (MVA) as Production Platform for Vaccines against Influenza and Other Viral Respiratory Diseases

Respiratory viruses infections caused by influenza viruses, human parainfluenza virus (hPIV), respiratory syncytial virus (RSV) and coronaviruses are an eminent threat for public health. Currently, there are no licensed vaccines available for hPIV, RSV and coronaviruses, and the available seasonal i...

Full description

Bibliographic Details
Main Authors: Arwen F. Altenburg, Joost H. C. M. Kreijtz, Rory D. de Vries, Fei Song, Robert Fux, Guus F. Rimmelzwaan, Gerd Sutter, Asisa Volz
Format: Article
Language:English
Published: MDPI AG 2014-07-01
Series:Viruses
Subjects:
modified vaccinia virus ankara
vaccine development
influenza virus
respiratory syncytial virus
parainfluenza virus
coronavirus
Online Access:http://www.mdpi.com/1999-4915/6/7/2735

Similar Items

Similar Items